A Dose Selection Study of Oral Calcitonin in Normal, Healthy, Postmenopausal Women.
Phase of Trial: Phase II
Latest Information Update: 08 Mar 2012
At a glance
- Drugs Calcitonin (Primary) ; Calcitonin (Primary)
- Indications Postmenopausal osteoporosis
- Focus Pharmacodynamics
- 08 Mar 2012 Detailed results will be published in a peer review journal and/or prestigious scientific congress, according to a Unigene Laboratories media release.
- 30 Apr 2010 Tarsa Therapeutics added as trial sponsor and trial affiliate as reported by ClinicalTrials.gov.
- 02 Apr 2008 Status changed from in progress to completed (source: ClinicalTrials.gov).